| Literature DB >> 35761147 |
Cristina Migliarese1, Alessandro Maloberti2,3, Roberto Gatto4, Michela Algeri1, Sara Scarpellini1, Cristina Giannattasio1,5.
Abstract
INTRODUCTION: A possible alternative to pharmacological antihypertensive therapies in grade 1 low risk hypertensive patients or in those experienced drugs adverse effects could be acupuncture. AIM: we focused on its possible effects on BP both as Office BP (OBP) and as Ambulatory BP Monitoring (ABPM) evaluating it before starting a 6 weeks twice weekly (total 12 session) acupuncture cycle and after 2 months from its completion.Entities:
Keywords: Acupuncture; Ambulatory blood pressure; Office blood pressure; Sympathetic activity
Mesh:
Substances:
Year: 2022 PMID: 35761147 PMCID: PMC9537129 DOI: 10.1007/s40292-022-00530-9
Source DB: PubMed Journal: High Blood Press Cardiovasc Prev ISSN: 1120-9879
baseline clinical, biochemical, echocardiographic data, cardiovascular risk factors and therapies of enrolled patients
| General data | |
| Number | 45 |
| Age (years) | 53.4 ± 11.2 |
| Males (%) | 36.2 |
| BMI (Kg/m2) | 23.9 ± 5.4 |
| Waist circ. (cm) | 90.6 ± 11.9 |
| Biochemical data | |
| Total cholesterol(mg/dL) | 204.1 ± 36.7 |
| LDL cholesterol(mg/dL) | 124.3 ± 31.5 |
| HDL cholesterol (mg/dL) | 59.7 ± 21.1 |
| Trigliceridi (mg/dL) | 118.1 ± 74.7 |
| Creatinine (mg/dL) | 0.8 ± 0.2 |
| Glucose (mg/dL) | 85.2 ± 19.0 |
| Echocardiographic data | |
| Ejection Fraction (%) | 63.1 ± 3.7 |
| LVMI (g/m2) | 98.3 ± 36.1 |
| Cardiovascular risk factors | |
| Sedentary life(%) | 41.9 |
| Smoking (%) | 11.6 |
| Menopause (%) | 31 |
| Diabetes Mellitus (%) | 7.1 |
| Peripheral arterial disease (%) | 4.8 |
| Obesity (%) | 7.1 |
| Dyslipidemia(%) | 35 |
| Previous myocardial infarction (%) | 2.4 |
| Previous stroke (%) | 2.4 |
| Antihypertensive therapies | |
| Antihypertensive therapies (%) | 47.6 |
| Beta-blockers(%) | 17.5 |
| Calcium channel blockers (%) | 17.1 |
| Diuretics (%) | 12.2 |
| Anti-Aldesteronic (%) | 7.3 |
| ACE inhibitors (%) | 7.3 |
| Angiotensin Receptor Blockers (%) | 22 |
| Alpha-antagonist (%) | 9.8 |
LDL Low Density Lipoprotein, HDL Digh Density Lipoprotein, LVMI Left Ventricular Mass Index; ACE Angiotensin Converting Inhibitors
Blood Pressure values at baseline and during follow-up
| T0 | T1 | p | ∆ variation | |
|---|---|---|---|---|
| Office SBP (mmHg) | 134.2 ± 15.7 | 125.1 ± 12.2 | 0.03 | − 8.6 ± 19.1 |
| Office DBP (mmHg) | 84.7 ± 12.8 | 81.4 ± 11.1 | 0.17 | − 3.5 ± 13.1 |
| SBP 24 h (mmHg) | 131.1 ±10.7 | 126.0 ± 10.1 | 0.01 | − 5.1 ± 11.5 |
| DBP 24 h (mmHg) | 85.3 ± 9.1 | 82.1 ± 7.5 | 0.03 | − 3.1 ± 6.6 |
| SBP day (mmHg) | 134.7 ± 10.5 | 127.1 ± 18.4 | 0.02 | − 7.6 ± 16.4 |
| DBP day (mmHg) | 88.5 ± 9.3 | 85.7 ± 7.8 | 0.02 | − 2.4 ± 6.9 |
| SBP night (mmHg) | 118.7 ± 11.8 | 117.5 ± 12.1 | 0.89 | − 1.9 ± 13.2 |
| DBP night (mmHg) | 74.1 ± 14.1 | 73.8 ± 9.4 | 0.49 | − 0.7 ± 14.1 |
| % dipping SBP (%) | 11.5 ± 7.3 | 9.1 ± 7.3 | 0.22 | − 2.2 ± 7.5 |
| % dipping DBP (%) | 13.8 ± 7.6 | 14.1 ± 8.8 | 0.68 | + 1.1 ± 8.5 |
| Normal dipper (%) | 37.8 | 39.5 | 0.42 | – |
| HR 24 h (bpm) | 71.1 ± 10.7 | 72.8 ± 12.6 | 0.15 | + 0.3 ± 18.3 |
BMI body mass index, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure
Fig. 1Office SBP (A) and DBP (B) and ABPM SBP (C) and DBP (panel D) before acupuncture initiation (T0) and after 2 months from cycle completion (T1)